"Vascular modulation and cancer therapy. Whats new!"
A Lola and John Grace Distinguished Lecture in Cancer Research
Hodivala-Dilke Kairbaan (Kebs) - Queen Mary University of London, Professor of the Tumour Microenvironment, Deputy Institute Director, Barts Cancer Institute, London, UK
Kairbaan Hodivala-Dilke did her PhD with Fiona Watt at ICRF, London (1990-1994); postdoc with Richard Hynes at MIT (1994-1999), USA, and was awarded tenure at the Imperial Cancer Research Fund (2004). After establishing her laboratory at The Barts Cancer Institute she became Professor of Angiogenesis (2009) and Deputy Institute Director (2012). British Society of Cell Biology, Hooke Medal, 2015. EMBO member and FMedSci 2015. Her research focuses is the cellular and molecular basis of tumour-stromal interactions, angiogenesis and therapy efficacy.
Hodivala-Dilke Kairbaan (Kebs) - Queen Mary University of London, Professor of the Tumour Microenvironment, Deputy Institute Director, Barts Cancer Institute, London, UK
Kairbaan Hodivala-Dilke did her PhD with Fiona Watt at ICRF, London (1990-1994); postdoc with Richard Hynes at MIT (1994-1999), USA, and was awarded tenure at the Imperial Cancer Research Fund (2004). After establishing her laboratory at The Barts Cancer Institute she became Professor of Angiogenesis (2009) and Deputy Institute Director (2012). British Society of Cell Biology, Hooke Medal, 2015. EMBO member and FMedSci 2015. Her research focuses is the cellular and molecular basis of tumour-stromal interactions, angiogenesis and therapy efficacy.
Practical information
- Informed public
- Free
- This event is internal
Organizer
- Prof. Freddy Radtke, Director ISREC
Contact
- Lisa Smith, ISREC Administrative Assistant (please contact me to obtain the Zoom passcode for this seminar). There are a limited number of in person places in conference room SV 1717, on the basis of first come, first served - 30 places maximum. A covid vaccination QR code or certificate is required for in person access.